Xylose
Xylo-pfan (xylose) is a small molecule pharmaceutical. Xylose was first approved as Xylo-pfan on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
92 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | 1 | 1 | — | 1 | 4 | 7 |
| Anesthesia | D000758 | — | 2 | 2 | 1 | 1 | 6 | ||
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | 1 | — | 2 |
| Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | 1 | — | 1 | — | 2 | 4 | ||
| Coronary artery disease | D003324 | I25.1 | — | 2 | 1 | — | — | 3 | |
| Coronary artery bypass | D001026 | EFO_0003776 | — | — | 2 | — | — | 2 | |
| Pulmonary surgical procedures | D013510 | — | — | 2 | — | — | 2 | ||
| Post-cardiac arrest syndrome | D000080942 | — | — | 1 | — | — | 1 | ||
| Coronary disease | D003327 | — | — | 1 | — | — | 1 | ||
| Panic disorder | D016584 | EFO_0004262 | F41.0 | — | 1 | 1 | — | — | 1 |
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | 1 | 1 | — | — | 1 |
| Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | 1 | — | — | 1 |
| Postoperative cognitive complications | D000079690 | — | — | 1 | — | — | 1 |
Show 3 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 4 | 2 | — | — | 1 | 6 |
| Idiopathic pulmonary fibrosis | D054990 | J84.112 | 1 | 2 | — | — | — | 3 | |
| Non-small-cell lung carcinoma | D002289 | 1 | 1 | — | — | 1 | 3 | ||
| Brain hypoxia-ischemia | D020925 | EFO_1000846 | P91.6 | 1 | 2 | — | — | 1 | 3 |
| Respiration disorders | D012120 | J00-J99 | 2 | 2 | — | — | — | 2 | |
| Covid-19 | D000086382 | U07.1 | — | 1 | — | — | 1 | 2 | |
| Vaping | D000072137 | 1 | 1 | — | — | 1 | 2 | ||
| Bronchiolitis obliterans | D001989 | EFO_0007183 | 1 | 1 | — | — | 1 | 2 | |
| Colorectal neoplasms | D015179 | — | 1 | — | — | — | 1 | ||
| Delirium | D003693 | R41.0 | — | 1 | — | — | — | 1 |
Show 10 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 1 | — | — | — | 1 | 2 |
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | 1 | — | — | — | — | 1 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | — | — | — | — | 1 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Premature birth | D047928 | EFO_0003917 | O60 | — | — | — | — | 1 | 1 |
| Bronchopulmonary dysplasia | D001997 | P27.8 | — | — | — | — | 1 | 1 | |
| Emphysema | D004646 | EFO_0000464 | J43 | — | — | — | — | 1 | 1 |
| Cholelithiasis | D002769 | EFO_0004799 | K80 | — | — | — | — | 1 | 1 |
| Cholecystitis | D002764 | HP_0001082 | K81 | — | — | — | — | 1 | 1 |
| Brain diseases | D001927 | HP_0001298 | G93.40 | — | — | — | — | 1 | 1 |
| Marijuana smoking | D008385 | — | — | — | — | 1 | 1 | ||
| Marijuana use | D000074609 | — | — | — | — | 1 | 1 | ||
| Lung injury | D055370 | S27.30 | — | — | — | — | 1 | 1 | |
| Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | 1 |
Show 9 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | XYLOSE |
| INN | — |
| Description | D-xylopyranose is d-Xylose in its pyranose form. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | OC1OC[C@@H](O)[C@H](O)[C@H]1O |
Identifiers
| PDB | — |
| CAS-ID | 58-86-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL502135 |
| ChEBI ID | 53455 |
| PubChem CID | 135191 |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 40,695 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
7 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more